Erratum: Diagnostic and therapeutic update of mantle cell lymphoma (MCL): analysis of seven cases treated in a centre in one year
Carmen Herrero-Vicent1, Isidro Machado2, Carmen Illueca2, Amparo Avaria3, Claudia Salazar3, Abraham Hernandez1, Sergio Sandiego1 and Javier Lavernia1
ecancer 10 627 (2016)
1Medical Oncology Department, Instituto Valenciano de Oncología, Valencia, Spain
2Pathological Anatomy Department, Instituto Valenciano de Oncología, Valencia, Spain
3Haematology Unit, Instituto Valenciano de Oncología, Valencia, Spain
Correspondence to: Carmen Herrero-Vicent. Email: carmendcn@hotmail.com
Copyright: © the authors; licensee ecancermedicalscience. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Published: 27/04/2016; Received: 11/04/2016
Table 3 was rendered incorrectly, please see the corrected table below.
Table 3. Clinical and analytical characteristics of patients.
On page 7, the line “• R-CHOP x six cycles, followed by rituximab (R) maintenance [14]” was repeated three times, whereas it should have only appeared once.
In Table 4: “CYCLINE D1”, should be “Cyclin D1” and “REORDERING”, should be “TRANSLOCATION”.
On page 5, “However, it is difficult to determine whether this is primary gastric (extranodal) mantle cell lymphoma with a lymphomatoid polyposis pattern or a secondary infiltration of the intestinal mucosa by a nodal mantle cell lymphoma.” should be “However, it is difficult to determine whether this is primary intestinal (extranodal) mantle cell lymphoma with a lymphomatoid polyposis pattern or a secondary infiltration of the intestinal mucosa by a nodal mantle cell lymphoma.”
On Page 8, “norblastoid variant” should be “non-blastoid variant”.
